Europe’s Divisional Patent Trap: How Big Pharma Delays Generics Without Ever Losing in Court
Europe’s “Divisional Patent Trap”: How Big Pharma Can Delay Generics Without Losing in Court
In patent law, the public often imagines a simple story: a company files a patent, the patent expires, generics arrive, and competition follows. But in Europe,…
